Cellular Biomedicine Group (CBMG) Swings to Q3 Loss
Tweet
Share
E-mailGet Alerts CBMG Hot Sheet
Join SI Premium – FREE
Cellular Biomedicine Group (NASDAQ: CBMG) reported Q3 EPS of ($0.31), versus $0.09 reported last year.
For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
